ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2023

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 240 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2023
NameSharesValueWeighting ↓
BNP PARIBAS FINANCIAL MARKETS 154,963$7,148,4430.01%
Vident Investment Advisory, LLC 5,893$271,8450.01%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 84,282$3,887,9280.01%
STATE OF WISCONSIN INVESTMENT BOARD 59,011$2,722,1770.01%
VANGUARD GROUP INC 7,018,502$323,763,4970.01%
State of New Jersey Common Pension Fund D 50,292$2,319,9700.01%
New Millennium Group LLC 200$9,2260.01%
Nuveen Asset Management, LLC 431,690$19,913,8600.01%
Arizona State Retirement System 19,722$909,7760.01%
GUGGENHEIM CAPITAL LLC 19,550$901,8410.01%
Treasurer of the State of North Carolina 29,553$1,3630.01%
TD ASSET MANAGEMENT INC 117,780$5,433,1910.01%
GILDER GAGNON HOWE & CO LLC 9,648$445,0620.01%
SHELL ASSET MANAGEMENT CO 3,479$1600.01%
GEODE CAPITAL MANAGEMENT, LLC 1,060,613$48,926,1070.01%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 242,928$11,206,2690.01%
BlackRock Inc. 5,067,027$233,741,9530.01%
XPONANCE, INC. 9,461$436,4360.01%
Man Group plc 42,277$1,950,2380.01%
TEACHER RETIREMENT SYSTEM OF TEXAS 19,049$8790.01%
External links

This page lists ULTRAGENYX PHARMACEUTICAL IN's shareholders in Q2 2023. To view ULTRAGENYX PHARMACEUTICAL IN's shareholder history, click here.